Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06819748

Efficacy and Safety of Cocktail of Ropivacaine for Local Infiltration Analgesia in Patients Undergoing Laparoscopic Cholecystectomy

Efficacy and Safety of Cocktail of Ropivacaine,sodium Bicarbonate and Dexamethasone for Incision Local Infiltration Analgesia in Patients Undergoing Ambulatory Laparoscopic Cholecystectomy:A Prospective Randomized Control Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
210 (estimated)
Sponsor
Sichuan Provincial People's Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to learn if the use of cocktail of ropivacaine,sodium bicarbonate and dexamethasone for incision local infiltration analgesia in patients undergoing ambulatory laparoscopic cholecystectomy is safe and effective. The main questions it aims to answer are: Does the cocktail lower the The incidence of moderate to severe pain during movement stages within six hours after surgery. Researchers will compare the cocktail to ropivacaine for incision local infiltration analgesia to see if the cocktail works to moderate the postoperative pain of ambulatory laparoscopic cholecystectomy patients. Participants will: Receive the cocktail or ropivacaine for incision local infiltration analgesia at the end of the surgery. Answer the questions about postsurgical pain at rest or during motion(using a Numeric Rating Scale (NRS) of 0 to 10. Pain measurements were performed at 2, 6, 12, 24 hours,3,7,30 days and 3 months postoperatively.

Conditions

Interventions

TypeNameDescription
DRUGThe cocktail of 0.5% ropivacaine ,5%sodium bicarbonate and 10 mg dexamethasoneThe patient receive the cocktail of 0.5% ropivacaine ,5%sodium bicarbonate and 10 mg dexamethasone as incision local anesthesia at the end of surgery
DRUG0.5% ropivacaineThe patient receive 0.5% ropivacaine as incision local anesthesia at the end of surgery

Timeline

Start date
2025-02-14
Primary completion
2025-06-01
Completion
2025-09-01
First posted
2025-02-11
Last updated
2025-02-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06819748. Inclusion in this directory is not an endorsement.